The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: emend     Quarter: 2016Q3

Total Drug/Injury Combinations: 233     Number of Pages: 12

DRUGNAME PT EventCount
EMEND (FOSAPREPITANT DIMEGLUMINE) Malignant neoplasm progression 2 view events
EMEND (FOSAPREPITANT DIMEGLUMINE) No adverse event 2 view events
EMEND (FOSAPREPITANT DIMEGLUMINE) Product use issue 2 view events
EMEND Abdominal pain 1 view events
EMEND Adverse reaction 1 view events
EMEND Amnesia 1 view events
EMEND Asthenopia 1 view events
EMEND Balance disorder 1 view events
EMEND Blood creatinine increased 1 view events
EMEND Blood lactic acid increased 1 view events
EMEND Blood pressure abnormal 1 view events
EMEND Blood pressure decreased 1 view events
EMEND Blood urine present 1 view events
EMEND Body temperature fluctuation 1 view events
EMEND Cardiac arrest 1 view events
EMEND Cardio-respiratory arrest 1 view events
EMEND Cerebrovascular accident 1 view events
EMEND Colon cancer 1 view events
EMEND Coma 1 view events
EMEND Dehydration 1 view events

Total Drug/Injury Combinations: 233     Number of Pages: 12

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)